Details of the Drug

General Information of Drug (ID: DMQMA3O)

Drug Name

SCF-I2

Synonyms

18531-96-9; 80703-23-7; 99827-46-0; 1,1'-binaphthalene-2,2'-dicarboxylic acid; (S)-1,1'-Binaphthyl-2,2'-Dicarboxylic Acid; (R)-[1,1'-Binaphthalene]-2,2'-dicarboxylic acid; (S)-[1,1'-binaphthalene]-2,2'-dicarboxylic acid; S-1,1'-binaphthyl-2,2'-dicarboxylic acid; 1-(2-carboxynaphthalen-1-yl)naphthalene-2-carboxylic Acid; [1,1'-Binaphthalene]-2,2'-dicarboxylic acid; (R)-1,1'-Binaphthyl-2,2'-Dicarboxylic Acid; 1,1'-Bi[2-naphthoic acid]; CHEMBL1231559; MFCD00185729; 1,1'-Binaphthalene-2,2'-dicarboxylic acid,(1S)-; 1,1'-Bi(2-naphthoic acid); 1,1'-binaphthyl-2,2'-dicarboxylic acid; ACMC-20a5ua; 1-(2-carboxynaphthyl)naphthalene-2-carboxylic acid; SCHEMBL895573; ZINC119674; (R)-1-(2-carboxynaphthalen-1-yl)naphthalene-2-carboxylic acid; 2555AC; 9691AA; ANW-58496; BDBM50428255; AKOS004903304; AKOS016006617; CCG-239105; MCULE-4910951739; SS-4976; SY243404; 1-(2-carboxynaphth-1yl)-2-naphthoic acid; FT-0689938; FT-0689939; FT-0689940; ST50542876; 1,1'-Binaphthyl-2,2'-dicarboxylic acid; (aR)-1,1'-Binaphthalene-2,2'-dicarboxylic acid; Q27458607; 1-(2-Carboxy-1-naphthyl)naphthalene-2-carboxylic acid; 1,1 inverted exclamation mark -Binaphthyl-2,2 inverted exclamation mark -dicarboxylic acid; (S)-[1,1 inverted exclamation mark -Binaphthalene]-2,2 inverted exclamation mark -dicarboxylic Acid; C1C

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Preclinical	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C22H14O4
Canonical SMILES: C1=CC=C2C(=C1)C=CC(=C2C3=C(C=CC4=CC=CC=C43)C(=O)O)C(=O)O
InChI: 1S/C22H14O4/c23-21(24)17-11-9-13-5-1-3-7-15(13)19(17)20-16-8-4-2-6-14(16)10-12-18(20)22(25)26/h1-12H,(H,23,24)(H,25,26)
InChIKey: YDZNRNHKJQTGCG-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 2810167
TTD ID: D06IHW

References

1	Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest. 2014 Jan;124(1):6-12.